ANZ Innovators Alimetry and The Clinician Among Five Winners In Medtronic APAC Innovation Challenge

Medtronic Australasia, a subsidiary of Medtronic plc (NYSE:MDT) — a global leader in healthcare technology — has announced that New Zealand digital health innovators Alimetry and The Clinician were among the five winners in the inaugural Medtronic APAC Innovation Challenge (MAIC).

Auckland-based Alimetry is a digital healthcare and medical device startup that develops breakthrough solutions for diagnosing disorders of gastrointestinal function.

"We're very excited to win this competition. Thanks to Medtronic for the opportunity to participate in this innovation challenge. This one offers a superb launching pad to take our technology to patients throughout the APAC region," said Professor Greg O' Grady, co-founder and CEO of Alimetry.

"The most valuable component for us was gaining access to Medtronic's panel of advisors, who were excellent. They were extremely knowledgeable and provided us with creative advice on the go-to-market strategy in the APAC region."

Also winning the challenge was digital health innovator, The Clinician, which supports healthcare organisations deliver better outcomes at a lower cost through timely exchange of patient-generated data and educational materials.

"We're absolutely delighted to be chosen as one of the five companies to collaborate with Medtronic. I want to thank the team at Medtronic that supported us, including our sponsors, in really helping to hone that business case for the final pitch," said Tamaryn Hankinson, co-founder and managing director, The Clinician.

All five winners from the challenge have the opportunity to collaborate with Medtronic to explore joint commercialisation of products and run commercial pilots for their proposed medtech or digital health product solutions, valued up to US$200,000.

"Congratulations to Alimetry and The Clinician for their achievement. These accolades are testament to the many healthcare technology innovations in ANZ and MAIC is an extension of our commitment to local innovation, that has the potential to go regional," said Liz Carnabuci, Medtronic Australasia vice president and managing director.

"MAIC provides a unique opportunity for ANZ innovators like Alimetry and The Clinician to tap into Medtronic's reach in APAC. At Medtronic we believe that no one company can solve the complex healthcare challenges that the world faces. As such, programs such as MAIC pave the way for collaborative innovations that can deliver impactful solutions unique to the region."

MAIC was launched in October 2021 as an extension of Medtronic Open Innovation Platform – an initiative aligned to Medtronic's bold new ambition to become the global leader in healthcare technology. Over 320 applications were received from 46 countries of which 10 companies were shortlisted to compete at a virtual challenge finale.

Winners were announced at the inaugural Medtronic APAC Innovation Conference held in Singapore on 16 March 2022. The conference also unveiled a whitepaper titled ‘Asia Pacific's Healthcare Technologies Ecosystem: Enhancing Start-up and SME success', written by the Economist Impact.

This first-ever study on the region's healthcare technology sector involves inputs from 150 executives from startups and business enterprises in APAC. To read the full findings, download the whitepaper here .

About MAIC

The Medtronic APAC Innovation Challenge (MAIC) provides an opportunity for innovators in the region to pitch and advance their development of MedTech solutions. The challenge also provides an opportunity to partner with Medtronic for a commercial pilot on their proposed MedTech, digital health or solution, valued up to US$200,000.

MAIC is facilitated via the inaugural Medtronic Open Innovation Platform, an initiative launched by Medtronic with support from the Singapore Economic Development Board.

The platform will bring strategic collaboration in healthcare technologies among various stakeholders across the healthcare ecosystem through capability development, partnerships and business organisations networking in areas of medical technology and digital health in APAC, with Singapore as the epicentre.

Focusing on the unique healthcare needs of APAC, this first-of-its-kind platform will enable Medtronic to explore and advance partnership opportunities that can help Medtronic leverage data, AI, and automation to address patient needs.

About Alimetry

Alimetry was founded in 2019 as a spin-out company from the University of Auckland's Bioengineering Institute and Faculty of Medical and Health Sciences. The company was founded on a background of world-leading science in gastrointestinal diseases. Alimetry is dedicated to improving the lives of patients by delivering innovative medical solutions to advance GI diagnostics and enable targeted therapies.

To learn more about Alimetry visit www.alimetry.com

About The Clinician

The Clinician is a digital health innovator redefining how healthcare is measured and delivered and is used by health systems globally to create streamlined digital care pathways and manage patient-generated health data. The Clinician enables care teams to monitor, engage and support patients along their entire healthcare journey while in the community. Interoperable with electronic medical record and practice management systems, The Clinician's cloud-based ZEDOC platform sits between healthcare organisations and patients outside the walls of the health system, enabling automated outreach, collection and analysis of patient-reported health data as well as the integration of wearable/medical device data and the delivery of multimedia educational materials.

To learn more about The Clinician, visit www.theclinician.com/

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, cranial and spinal robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for all. In everything we do, we are engineering the extraordinary.

For more information on Medtronic Australia and New Zealand, visit www.Medtronic.com.au and follow @MedtronicANZ on Twitter and LinkedIn .

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Ryan Weispfenning
Investor Relations
+1-763-505-4626

Andre Varella
Public Relations
+61-459-404-011

News Provided by Business Wire via QuoteMedia

MDT
The Conversation (0)

PrairieSky Announces First Quarter 2024 Results, Record Oil Royalty Production

-

PrairieSky Royalty Ltd. ("PrairieSky" or the "Company") (TSX: PSK) is pleased to announce its first quarter ("Q1 2024") operating and financial results for the three-month period ended March 31, 2024.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

PrairieSky Announces Fourth Quarter And Year-End Results For 2023, Including Record Oil Royalty Production, Strong Leasing Activity And Increased Annual Dividend

PrairieSky Royalty Ltd. (" PrairieSky " or the " Company ") (TSX: PSK) is pleased to announce its fourth quarter (" Q4 2023 ") and year-end operating and financial results for the period ended December 31, 2023. PrairieSky is also pleased to announce a 4% increase in its annual dividend to $1.00 per common share ($0.25 per common share quarterly).

Fourth Quarter Highlights

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

PrairieSky Announces 2023 Third Quarter Results

PrairieSky Royalty Ltd. (" PrairieSky " or the " Company ") (TSX: PSK) is pleased to announce its third quarter (" Q3 2023 ") results for the three-month period ended September 30, 2023.

Third Quarter Highlights

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
doctor with hands together, palms up below digital medical symbols

Innovations and Opportunities in European Healthcare Technologies

In recent years, European companies have emerged as trailblazers in healthcare technology, effectively changing the face of health and patient care. Through innovation, they're not only improving systems, processes and patient outcomes but also saving lives.

These advanced European technologies are often only distributed and implemented exclusively within the European Union. The good news is that it doesn't need to stay this way.

Bringing European healthcare technologies to the North American market can potentially improve healthcare in this part of the world, open up new market opportunities for investors and expose those companies to significant growth capital.

Keep reading...Show less

Thermo Fisher Scientific Reports First Quarter 2024 Results

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024.

First Quarter 2024 Highlights

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
March Quarterly Appendix 4C

March Quarterly Appendix 4C

Cardiex Limited (ASX:CDX) (Cardiex, the Company) has released its Quarterly Cash Flow Report.


Keep reading...Show less
Cardiex March 2024 Quarter Update

Cardiex March 2024 Quarter Update

Cardiex Limited (ASX:CDX) (Cardiex, the Company) is pleased to present its Quarterly Report.
Keep reading...Show less

Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity

According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues

Americans overwhelmingly say that when they think about longevity, it's more than just living longer - it's about living their healthiest, best lives. While most want to live to 90-well past the average U.S. life expectancy of 77.5 years-nearly two-thirds (66%) would choose a shorter, healthier life over a longer one with health issues. These findings, from a survey conducted by global healthcare technology leader Medtronic with Morning Consult, highlight a gap between U.S. adults' desire to live healthier years and the opportunity for more people to improve their quality of life through healthcare technology

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Americans favor quality over quantity in pursuit of longevity

According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues

Americans overwhelmingly say that when they think about longevity, it's more than just living longer—it's about living their healthiest, best lives. While most want to live to 90—well past the average U.S. life expectancy of 77.5 years—nearly two-thirds (66%) would choose a shorter, healthier life over a longer one with health issues. These findings, from a survey conducted by global healthcare technology leader Medtronic with Morning Consult, highlight a gap between U.S. adults' desire to live healthier years and the opportunity for more people to improve their quality of life through healthcare technology.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×